OABI
OABI
NASDAQ · Life Sciences Tools & Services

Omniab Inc

$4.89
-0.02 (-0.41%)
Financial Highlights (FY 2026)
Revenue
24.16M
Net Income
-83,832,392
Gross Margin
98.4%
Profit Margin
-347.0%
Rev Growth
-31.9%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 98.4% 98.4% 31.4% 31.4%
Operating Margin -369.5% -332.5% 6.8% 7.4%
Profit Margin -347.0% -329.7% 5.9% 5.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 24.16M 35.47M 184.39M 150.46M
Gross Profit 23.77M 34.90M 57.85M 47.20M
Operating Income -89,269,079 -117,959,434 12.45M 11.10M
Net Income -83,832,392 -110,775,440 10.85M 8.86M
Gross Margin 98.4% 98.4% 31.4% 31.4%
Operating Margin -369.5% -332.5% 6.8% 7.4%
Profit Margin -347.0% -329.7% 5.9% 5.9%
Rev Growth -31.9% -31.9% +2.4% +24.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 119.74M 97.60M
Total Equity — — 186.51M 185.21M
D/E Ratio — — 0.64 0.53
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -72,539,061 -101,177,665 16.49M 14.30M
Free Cash Flow — — 4.93M 6.48M